What does multi-morbidity mean for cancer treatment and outcomes

Chair: Peter Murchie, University of Aberdeen, UK
Speaker: David Blane, University of Glasgow, UK
Speaker: Peter Rainey, NCRI Consumer Forum, UK
Speaker: Katriina Whitaker, University of Surrey, UK


Room: Dochart

An ageing population means that cancer is increasingly diagnosed in older people with co-existing health conditions. This issue has major implications for diagnosing and treating cancer, and also for caring for cancer survivors in the longer term. In this session international experts will discuss key challenges and state-of-the art research findings with respect how comorbidities can influence diagnosis, treatment and outcomes from cancer. Crucially, the session will also consider how people with cancer experience and deal with comorbidity during their cancer journey. Session